← Leaderboards
Michael R. Bristow
University Of Colorado Denver
$7,111,960
Attributed
$7,111,960
Total exposure
12
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $699.9K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$7,111,960 · 12
By mechanism
R01$5,914,298 · 3
M01$964,673 · 8
T32$232,989 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Matthew R Taylor$5,502,265
- Brian L Stauffer$5,871,842
- Sonia Castro Flores$16,461,738
- Mark L Dell'acqua$24,552,179
- Kathryn C. Chatfield$1,499,821
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchGene ExpressionBeta Antiadrenergic AgentHeart FailureHuman Therapy EvaluationPolymerase Chain ReactionRenin Angiotensin SystemHeart CatheterizationCongestive Heart FailureHeart Disorder ChemotherapyHeart FunctionMyosinsEchocardiographyDrug Administration Rate /DurationIdiopathic Dilated CardiomyopathyBeta Adrenergic ReceptorHeart Imaging /Visualization /ScanningAdrenergic ReceptorMagnetic Resonance ImagingLongitudinal Human StudyMolecular PathologyCardiovascular Disorder ChemotherapyHeart Ventricle
Grant awards (34)
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION$1,187
M01 · FY2008 · RR · contact PI
Genetic-Adrenergic Interactions in Myocardial Failure$660,384
R01 · FY2007 · HL · contact PI
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION$10,099
M01 · FY2007 · RR · contact PI
Genetic-Adrenergic Interactions in Myocardial Failure$673,014
R01 · FY2006 · HL · contact PI
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION$26,921
M01 · FY2006 · RR · contact PI
Genetic-Adrenergic Interactions in Myocardial Failure$673,734
R01 · FY2005 · HL
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION$20,588
M01 · FY2005 · RR
Genetic-Adrenergic Interactions in Myocardial Failure$588,259
R01 · FY2004 · HL
Genetic-Adrenergic Interactions in Myocardial Failure$128,312
R01 · FY2004 · HL
Beta-Blocker Effect on Remodeling and Gene Expression$14,042
M01 · FY2004 · RR
ALTERED GENE EXPRESSION IN THE FAILING HUMAN HEART$447,428
R01 · FY2003 · HL
Dynamic Expression Profiling in the Intact Human Heart$153,000
R01 · FY2003 · HL
ALTERED GENE EXPRESSION IN THE FAILING HUMAN HEART$445,839
R01 · FY2002 · HL
CONTRACTILE PROTEIN EXPRESSION IN FAILING HUMAN HEART$377,500
R01 · FY2002 · HL
BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE$190,747
M01 · FY2002 · RR
EFFECTS OF CHRONIC TRTMNT WI BUCINDOLOL HCL OR METOPROLOL TARTRATE$190,747
M01 · FY2002 · RR
Dynamic Expression Profiling in the Intact Human Heart$151,000
R01 · FY2002 · HL
ALTERED GENE EXPRESSION IN THE FAILING HUMAN HEART$437,103
R01 · FY2001 · HL
CONTRACTILE PROTEIN EXPRESSION IN FAILING HUMAN HEART$377,500
R01 · FY2001 · HL
EFFECTS OF CHRONIC TRTMNT WI BUCINDOLOL HCL OR METOPROLOL TARTRATE$190,747
M01 · FY2001 · RR
BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE$190,747
M01 · FY2001 · RR
BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE$0
M01 · FY2001 · RR
EFFECTS OF CHRONIC TRTMNT WI BUCINDOLOL HCL OR METOPROLOL TARTRATE$0
M01 · FY2001 · RR
ALTERED GENE EXPRESSION IN THE FAILING HUMAN HEART$423,725
R01 · FY2000 · HL
CONTRACTILE PROTEIN EXPRESSION IN FAILING HUMAN HEART$377,500
R01 · FY2000 · HL
POSTGRADUATE TRAINING IN CARDIOVASCULAR RESEARCH$232,989
T32 · FY2000 · HL
EFFECTS OF CHRONIC TRTMNT WI BUCINDOLOL HCL OR METOPROLOL TARTRATE$32,212
M01 · FY2000 · RR
PARALLEL, DOSE RESP STUDY--SUSTND RELEASED MOXONIDINE IN CHF PATIENTS$32,212
M01 · FY2000 · RR
EFFICACY OF IV MILRINONE IN PATIENTS WITH CONGESTIVE HEART FAILURE$32,212
M01 · FY2000 · RR
BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE$32,212
M01 · FY2000 · RR
BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE$0
M01 · FY2000 · RR
PARALLEL, DOSE RESP STUDY--SUSTND RELEASED MOXONIDINE IN CHF PATIENTS$0
M01 · FY2000 · RR
EFFECTS OF CHRONIC TRTMNT WI BUCINDOLOL HCL OR METOPROLOL TARTRATE$0
M01 · FY2000 · RR
EFFICACY OF IV MILRINONE IN PATIENTS WITH CONGESTIVE HEART FAILURE$0
M01 · FY2000 · RR